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PURPOSE. To introduce a perimetric algorithm (gradient-oriented automated natural neighbor
approach [GOANNA]) that automatically chooses spatial test locations to improve
characterization of visual field (VF) loss without increasing test times.
METHODS. Computer simulations were undertaken to assess the performance of GOANNA.
GOANNA was run on a 38 grid of 150 locations, and was compared with a zippy estimation by
sequential testing (ZEST) thresholding strategy for locations in the 24-2 test pattern, with the
remaining 98 locations being interpolated. Simulations were seeded using empirical data from
23 eyes with glaucoma that were measured at all 150 locations. The performance of the
procedures was assessed by comparing the output thresholds to the input thresholds
(accuracy and precision) and by evaluating the number of presentations required for the
procedure to terminate (efficiency).
RESULTS. When collated across whole-fields, there was no significant difference in accuracy,
precision, or efficiency between GOANNA and ZEST. However, GOANNA targeted
presentations on scotoma borders; hence it was more precise and accurate at locations
where the sensitivity gradient within the VF was high.
CONCLUSIONS. Compared with ZEST, GOANNA was marginally less precise in areas of the VF
that had spatially uniform sensitivity, but improved accuracy and precision in regions
surrounding scotoma edges. GOANNA provides a principled framework for automatic
placement of additional test locations to provide spatially denser testing around the borders of
VF loss.
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The spatial resolution in the commonly used 24-2 and 30-2programs of the Humphrey field analyzer (HFA; Zeiss
Humphrey Systems, Dublin, CA, USA) is restricted to an equally
spaced 68 3 68 rectangular grid. However, previous research has
demonstrated that a 68 3 68 rectangular grid is too coarse to
detect subtle defects and has limited ability to detect small
spatial changes in subsequent tests.1–5 Condensed grids with
higher spatial resolution are able to identify scotomata beyond
the resolution of conventional perimetry.1–9 These discoveries
suggest that the spatial resolution of conventional perimetry is
not high enough to detect early glaucomatous change.
Approaches to increase the spatial resolution of visual field
(VF) tests have been examined in the past,3–5,8–16 but have not
been suitable for clinical application. Haeberlin and col-
leagues15 reported a procedure called the Spatially Adaptive
Program (SAPRO), which tested locations at resolutions of 3.28,
1.68, and 0.88.14,17,18 It was recognized that the long test
duration of SAPRO was a major limitation of this procedure,
where 236 presentations were required to examine a 158 field
with a 3.28 grid.14 More recently, scotoma-oriented perimetry
(SCOPE)5,11 and fundus-oriented perimetry (FOP)4,16,19,20 have
been reported, which involve a clinician selecting more points
to test within a region of interest. A procedure that
automatically adds a fixed number of locations for further
testing to a completed 24-2 pattern by computing the gradient
between previously tested locations has also been proposed
recently (Aoyama K, et al. IOVS 2013;54:ARVO Abstract 3914).
The aim of this study was to develop an automated approach
to choose spatial test locations in order to improve character-
ization of VF loss without increasing test times. The resulting
approach is a novel perimetric procedure, the gradient-oriented
automated natural neighbor approach (GOANNA). GOANNA
begins with a pool of possible test locations, and autonomously
selects stimulus locations during a VF test. The locations are
chosen so regions surrounding scotoma borders receive
increased spatial resolution, without increasing test times over
those procedures that use a fixed pattern of locations like the
zippy estimation by sequential testing (ZEST).21–23
ZEST was chosen as our baseline as it has been shown to
perform better than Swedish interactive threshold algorithms
(SITA) and full threshold in terms of accuracy and precision of
sensitivity estimates.23 It displays reduced test–retest variability
compared with full threshold, particularly when the initial
estimates used by the procedures are remote from the true
threshold for the location (e.g., at scotomata edges).23,24
Furthermore, the mechanics of SITA are not available in the
public domain, making comparisons using simulation impossi-
ble.
The aim of GOANNA is to improve precision (degree of test–
retest variability) and accuracy (true threshold less measured
threshold) of threshold estimates, while maintaining efficiency
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(number of presentations) compared with current approaches.
These procedures were tested through computer simulations
seeded with fields prospectively collected on a 38 grid covering
the central 218 of vision with exception to the nasal region,




Simulation allows thousands of threshold estimates to be
obtained rapidly and has been used previously to evaluate
clinical test algorithms prior to clinical application.21,25–28 A
key advantage of simulation over clinical studies is that the true
threshold is known, and sources of measurement error can be
introduced at a desired rate, hence their effects on individual
test procedures can be studied.
Test procedures are run with a simulated patient respond-
ing as if the input thresholds were the patient’s true threshold,
incorporating responses based on the modelled patient’s
frequency of seeing (FOS) curve and predetermined rate of
false-negative (FN) and false-positive (FP) responses. A typical
FP response error profile (15% FP, 3% FN) was investigated,
which has been used previously.29 Reliable (0% FP, FN), typical
false negative (3% FP, 15% FN) and unreliable (20% FP, 20% FN)
conditions were also fully explored, and are included in a
supplementary section. The slope of the FOS curve for a given
threshold was modelled as the SD of a cumulative Gaussian
distribution determined in accordance to published variability
formulae,30 capped to a maximum of 6 dB. This was achieved
using the ‘‘SimHenson’’ mode of the open perimetry interface
(OPI).31
The performance of procedures was assessed by the
differences between output and input thresholds (median for
accuracy, interquartile range for precision) and by comparing
the number of presentations required for the procedure to
terminate (efficiency). Simulations were run 50 times on each
of the 23 fields, resulting in 1150 trials.
Input Visual Fields
In order to test algorithm performance on fields with dense
spatial locations, empirical data was collected on a 38 grid of
150 locations on an Octopus 900 (Haag Streit AG, Koeniz,
Switzerland) perimeter. The Octopus dB scale is defined as
10 3 logðLmax=LstimulusÞ, where Lmax is the maximum stimulus
luminance and Lstimulus is the stimulus luminance. We set the
background intensity at 10 cd/m2 (31.4 apostilbs [asb]) with
the maximum stimulus intensity being 1273 cd/m2 (4000 asb).
A Goldmann Size III target was used. The ZEST test strategy
with uniform prior probability mass functions (PMFs) was used
to measure sensitivity at each location (Refer to Test
Procedures section for a detailed description of ZEST). In
order to get a relatively unbiased estimate of the spatial
characteristics of the VFs, uniform priors were used (where
each possible threshold is initially considered equally probable
for the location being tested). Nonuniform priors used in
clinical procedures speed up tests, but show bias toward the
most-likely thresholds in the assumed threshold distribution.32
Because testing with uniform priors requires more presenta-
tions than typical clinical procedures (but results in better
accuracy), testing was split into eight separate tests, with each
partial test completing around 20 locations across the whole
field in approximately 6 minutes. Short breaks were provided
between each partial test. The OPI31 was used to run the
procedure.
Twenty-three clinically diagnosed glaucoma participants
were tested. A histogram of the input sensitivities from these
23 fields (3450 locations in total) can be seen in Figure 1.
Participants with visual acuity less than 6/9, refractive error
greater than 66 diopters (D; spherical equivalent), migraine,
diabetes, tilted optic discs, or any other optic disc abnormal-
ities or ocular diseases other than glaucoma were excluded. For
each participant, a single eye was tested; if both eyes satisfied
the criteria then one eye was chosen at random.
Twenty-one participants had their VF measured twice on
separate days, and two participants were measured once. The
fields used as input for the simulation were the average of the
two fields taken, all converted to right eye format.
The Ocular Hypertension Treatment Study scotoma classi-
fication system33 was used to classify the scotoma patterns
observed in our sample: three altitudinal, two partial periph-
eral rim, six widespread loss, two superior depression, five
arcuate, one inferior depression, and four nasal step defects.
The data collection followed the tenets of the Declaration of
Helsinki and written informed consent was obtained from the
subjects after explanation of the nature and possible conse-
quences of the study. Human research ethics approval for the
study was obtained from the University of Melbourne Human
Research Ethics Committee.
Test Procedures
ZEST Algorithm. The ZEST implementation used for the
simulations was performed using the OPI.31 The ZEST
procedure is based on a maximum-likelihood determination
described previously in the literature.21,34 At each tested
location, a PMF over the domain 5 to 40 dB is chosen as a
prior, and the mean of the prior PMF is presented. Depending
upon the patient’s response, a likelihood function (which
represents the likelihood of patient seeing a stimulus) is
multiplied with the prior PMF to generate a new PMF. The
likelihood function used in these simulations is the same as in
previous studies.23 The mean of the new PMF is then
presented for the next response. This process continues until
the SD of the PMF is less than 1.5 dB. The mean of final PMF
upon termination is taken as the output threshold.
FIGURE 1. Histogram of input sensitivities of the 23 input fields used in
the simulations.
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In this study, the prior PMF at each location was either
uniform, where all probabilities are the same, or bimodal, with
one peak at 0 dB modelling thresholds of damaged locations,
and a second peak at M dB, where M varies for each
location.22,23,34 We adopted the approach of the Humphrey
Field Analyzer 24-2 ‘‘growth pattern’’ for choosing M.35 With
this approach, four primary locations (698, 698) have M set to
26 dB. Once the final thresholds are determined for these
locations, the immediate neighbors set their M value to the
value of the primary location. After these 24 locations
terminate, their immediate neighbors take their M values as
the mean of their neighbors, and so on.
GOANNA Algorithm. Unlike conventional test patterns
and our ZEST implementation, GOANNA contains a pool of
potential test locations, some of which will be used for
stimulus presentations, and some that may not; the points
tested are chosen dynamically during the test. Like other
Bayesian procedures,21,36 each location maintains a discrete
PMF over all possible threshold values for that location. As per
ZEST, we use a domain of 5, 4, ..., 40 dB.
Some locations are deemed ‘‘seed locations,’’ and these are
given a prior PMF before the test begins. We report results for
both uniform priors, and bimodal priors with M equaling 26
dB.
At any point during the test, a location can be ‘‘active,’’ if it
has had at least one presentation; ‘‘inactive,’’ if it has never had
a presentation; or ‘‘finished’’ if its PMF has reached some
predetermined termination criteria.
The general structure of GOANNA is as follows:
1. Decide on a set of locations that covers the desired VF.
Choose a subset of these locations as seed points, assign
them a prior PMF and mark them as active;
2. While the termination criteria is not met:
a. Choose any active or inactive location for presenta-
tion;
b. If the location is inactive, make a PMF for that location
using natural neighbor interpolation of neighboring
active or finished points (see later for details); and
c. Present at the mean of that PMF and update PMF as in
ZEST.
3. Create PMFs for inactive locations upon termination
criteria being met.
We now elaborate on each step.
Step 1 – Locations and Seeds
Figure 2 shows the locations used for the 38 grid. There are 150
possible test locations and 36 seed locations. Presentations are
first given at the seed locations until the SD of their PMFs falls
below 6 dB.
Step 2a – Location for Presentation
If there is an active location that has a PMF with SD greater
than 6 dB, it is chosen. Otherwise, the gradient between all
FIGURE 2. Seed pattern implemented in GOANNA. Seed locations are
denoted by the black squares and nonseed locations by the grey
squares.
FIGURE 3. A Voronoi tessellation used in natural neighbor interpolation (A). The location in red is the location to be interpolated. The decibel value
for the red dot is the weighted sum of the five colored dots, with the weights being proportional to their areas of overlap with the red polygon.
Filled dots denote active locations and unfilled dots denote inactive locations. (B) The resultant PMF of the interpolated location from ([A]; shown
in red). The locations marked ‘A’ and ‘B’ are the location pair with the steepest gradient. Vertical green lines denote true threshold. The locations
shaded in grey are the locations that have already terminated. Np¼ number of presentations; ex¼ expected mean.
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pairs of active and finished locations are calculated. The
gradient is given as the difference in the expectation (mean) of
the PMFs divided by the distance in degrees between two
points. The location closest to the midpoint of the pair of
locations with the greatest gradient is chosen, with ties broken
at random. If the locations that form the pair are neighbors and
do not have any locations in between, then one of the two
locations will be selected at random to be tested if they are
both active. If one location of that pair is finished, then the
unfinished, active location will be tested. If both locations are
finished, then the location pair with the second largest gradient
is used to find a location to test, and so on.
Step 2b – Making a PMF for an Inactive Location
When an inactive location is chosen to be tested, its PMF is
determined by natural neighbor interpolation37,38 on active
and finished points (Fig. 3). This form of interpolation forms a
Voronoi tessellation37,38 of the field using polygons around
each active or finished point. Each polygon encloses the area
that is closest to its location compared with the other
locations. After this, a second Voronoi tessellation is created
but that includes the new, inactive location. The polygon of the
inactive location (outlined in red in Fig. 3) is then superim-
posed on top of the initial tessellation.
To create the new PMF for this location, a weighted average
of the PMFs over the neighbors of this point is then calculated,
with the weights proportional to the amount of overlap the
inactive location polygon has with the polygons of its
neighbors. After the interpolation, the PMF is scaled such that
the minimum probability is no less than 0.002. An example of a
PMF creation is shown in Figure 3B.
Step 2c – Updating the PMF
The prior PMF is updated based on the response given. It is
multiplied by either a ‘‘yes’’ or ‘‘no’’ likelihood function,
depending on whether the stimulus was seen or unseen,
respectively. The likelihood functions used for GOANNA were
the same as described for ZEST.
Step 3 – Termination Criteria and Creating PMFs
for Inactive Locations After Termination
GOANNA repeats steps 2a, b and c until a predefined minimum
number of presentations have been used, or until all individual
locations terminate: whichever is first. The minimum is
imposed to ensure that for uniform fields the procedure does
not terminate with many locations untested. In the simula-
tions, this predefined number was matched to the median
number of presentations of ZEST run on the same data set.
Once the limit is reached, if the largest gradient between all
pairs of active and finished locations is greater than 6 dB/deg,
GOANNA will continue to run until either the maximum
gradient among active and finished pairs is less than 6 dB/deg
or all locations have completely terminated. If there are
inactive locations upon termination, these locations are
assigned a PMF by natural neighbor interpolation, in the same
way a prior is created in Step 2b.
GOANNA Compared With ZEST With Interpolation
on a 38 Grid
The performance of GOANNA on a dense grid of 150 locations
was compared with Bimodal ZEST with a growth pattern on a
standard 24-2 grid of 52 locations, obtaining thresholds for the
other unmeasured locations through natural neighbor interpo-
lation. Locations in the blind spot (158 6 38, 08 6 38) were not
tested. Absolute error (absolute difference between true and
measured thresholds) was examined for three location groups:
(1) all locations, (2) non 24-2 locations, and (3) 24-2 locations.
Results from all locations of the 23 fields were pooled for
analysis of absolute error and total number of presentations. A
Wilcoxon rank sum test was performed to compare the median
absolute error (MAE) of GOANNA and ZEST.
FIGURE 4. Boxplots of GOANNA and ZEST for the typical FP responder. Left column: absolute error and total presentations at all locations. Middle
column: absolute error and total presentations at non 24-2 locations. Right column: absolute error and total presentations at 24-2 locations.
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In order to examine the spatial behavior of GOANNA,
locations were grouped by their Max_d value, where Max_d is
the greatest difference in sensitivity (dB) between a location
and any eight of its adjacent locations (ignoring the omitted
locations at the blind spot). Hence, a location with a high
Max_d value would be at the edge of a scotoma. Conversely, a
location with a low Max_d would be in an area of uniform
sensitivity. Boxplots and difference plots of locations by
proximity to scotoma edges (Max_d) were plotted.
RESULTS
Although a number of variations on the ZEST and GOANNA
procedures were investigated (varying type of prior PMFs,
termination criteria, seed location pattern, and growth pattern
versus no growth pattern), only the ZEST and GOANNA
procedures that performed the best in each simulation are
reported here.
While the MAE of bimodal GOANNA was statistically higher
than ZEST (2.00 vs. 1.91 dB, Wilcoxon P < 0.001; interquartile
range [IQR] 3.30 vs. 2.94 dB) across all locations (Fig. 4), the
magnitude of difference is almost certainly not clinically
significant. The median number of presentations was equal
for both procedures but the IQR was significantly lower in
bimodal GOANNA (8 vs. 61). Over the non 24-2 locations,
bimodal GOANNA had an equal MAE to ZEST (2.0 dB). As
expected, ZEST performed better than bimodal GOANNA in
terms of both MAE (1.99 vs. 1.75 dB, Wilcoxon P < 0.001) and
IQR (3.25 vs. 2.42 dB) over the 24-2 locations. This is because
GOANNA does not use as many presentations at these
locations as ZEST. It is also apparent in Figure 4 that GOANNA
FIGURE 5. Top: Boxplots of absolute error for ZEST and GOANNA in terms of Max_d in the typical FP responder. Bottom: difference plots of ZEST
less GOANNA in terms of Max_d. Values in the positive range indicate where GOANNA performs better than ZEST.
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with a bimodal prior is slightly superior to GOANNA with a
uniform prior, and so we use a bimodal prior from now on.
Figure 4 illustrates that GOANNA performs approximately
the same as ZEST on average over whole fields. However,
GOANNA is designed to target regions of high gradient in the
field. Therefore, it would be expected that it should have lower
MAE in areas around the edges of scotomata compared with
ZEST. Figure 5 separates locations in the field by their
proximity to a scotoma border (Max_d).
The boxplots in Figure 5 illustrate that the absolute error of
ZEST increases as Max_d increases. However, GOANNA does
not exhibit this trend, as absolute error is lowest at both high
and low Max_d. The difference plots in the bottom two rows
of the figure reveal that GOANNA performs better than ZEST
when the Max_d is between 12 and 29 dB across all locations
(Fig. 5, left column). Similarly, GOANNA exhibits lower IQR
within a similar region (17–29 dB). ZEST exhibits lower MAE at
0 to 11 dB (with the exception at 1 dB), and lower IQR at 2 to
11 dB compared with GOANNA. Furthermore, it can be seen
that ZEST performs better over the 24-2 locations (Fig. 5, right
column). The real gains for GOANNA are in the locations that
are at the edges of scotomata (high Max_d).
In Figure 6, it is evident that GOANNA spends more
presentations at locations near a scotoma edge (high Max_d),
and less presentations at locations in the middle of a scotoma
or normal region (low Max_d). Furthermore, ZEST expends
more presentations on the 24-2 locations than GOANNA (right
column in Fig. 6).
Figure 7 provides a comparison of a global measure, mean
deviation (MD), and the variability of this measure between
GOANNA and ZEST. Of the 23 input fields, GOANNA displayed
lower MD variability than ZEST in 16 fields and higher
variability in nine fields.
A typical result of GOANNA’s performance is shown in
Figure 8. The input field shows a deep circumscribed arcuate
defect that affects the immediate superior paracentral region
(Fig. 8A). The locations in bold denote the 24-2 locations. It
can be seen that the majority of presentations lie within the
area that corresponds to that arcuate defect (Fig. 8C). The
numbers shown at each location represent the median over the
50 repeats for these fields. In fields that are normal (Figs. 8D–
F), it can be seen that GOANNA does not find a VF region to
test more densely as there is no detected localized loss.
DISCUSSION
Earlier studies looking at spatially high resolution stimulus
arrangements possess one or more of the following limitations:
(1) test duration is too high to be applied within a clinical
setting, (2) additional locations need to be manually added by a
trained operator, (3) total area covered by the test is reduced to
limit the number of presentations, or (4) the output of
FIGURE 6. Top: Boxplots of presentations for bimodal ZEST and bimodal GOANNA for Max_d between adjacent locations in the typical FP
responder. Locations on the edge of a scotoma will have a high maximum difference in sensitivity. Bottom: difference plots of median number of
presentations (ZEST less GOANNA) for Max_d.
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perimetric data obtained is not in a standard format, thus
making it difficult to interpret the results for nonexperts.
GOANNA was designed to overcome all four shortcomings.
The results have shown that on average over the whole
field, bimodal GOANNA performs similarly to bimodal ZEST
with a growth pattern (Fig. 4). But if the field is separated into
areas of uniform sensitivity (low Max_d) and nonuniform
sensitivity (high Max_d), differences between the procedures
emerge (bottom two rows of Fig. 5). GOANNA spends more
presentations at locations bordering scotomata. Sensitivities
obtained in areas of the field surrounding scotomata are more
precise and accurate with GOANNA. These results suggest that
GOANNA would be more sensitive to spatial changes of a
scotoma, but not subtle deepening of the center of a large
defect. Therefore, we predict that GOANNA would be able to
detect progression of a scotoma earlier than ZEST when
progression involves spatial spread more so than defect
deepening.
As illustrated in Figure 8, GOANNA is able to identify
scotomata and test more locations within those regions of
visual deficit. The nature of the dynamic stopping criteria that
is implemented in GOANNA allows for early identification and
termination if a field is normal, but also allows for more
presentations to be spent if there is a localized scotoma
identified. The tradeoff is that GOANNA does not sample as
densely in normal regions of VF compared with ZEST, and thus
is neither as accurate nor precise as ZEST in these areas.
There may also be benefits in the spatial pattern of
GOANNA’s stimulus location choices. After sampling coarsely
over the hill of vision, GOANNA first targets regions of
localized loss, which are typically highly variable. On the
contrary, the Humphrey growth pattern implemented in ZEST
and SITA tests central locations first, and peripheral locations
last.35 Hence, areas of loss in the periphery do not receive
presentations until well into the test. By testing these areas
first, GOANNA may minimize fatigue effects39 at these
locations, and hence may reduce the variability caused by
fatigue in these regions.
Naturally, there are still limitations on the spatial resolution
of GOANNA. Here we have experimented with a grid pattern
spaced at 38, rather than the more conventional 68 grid. Thus,
scotomata smaller than 38 can still remain undiscovered. There
are two input parameters to GOANNA that control the
likelihood of detecting small scotomata. The first is the set of
possible locations, which can be made as large as one desires,
but, with a limited number of presentations, in large sets many
locations will never receive presentations. The second is the
location of the seed points. If an isolated scotoma falls between
seed points that have normal sensitivity, then they are unlikely
to be detected unless the total number of locations is small.
There is a tradeoff between the number of locations tested,
and the location of seed points. Exploring this tradeoff is work
in progress in our lab. Also, if GOANNA were to be applied
clinically, it may be important to consider distinguishing for the
clinician between those locations where threshold was
estimated following direct participant response, and those
which were estimated by interpolation.
It has recently been argued that the coarse sampling of most
current VF patterns with size III targets, when combined with
microsaccadic fixational eye movements, contributes signifi-
cantly to perimetric test–retest variability in areas of VF loss.1
The author formalizes the concept that the spatial pattern of
measured VF defects will depend on the sampling grid, in part
due to spatial aliasing, and illustrates the contribution of such
undersampling to measured variability. If true VF defects are
patchy and include high spatial frequency detail, they cannot
be accurately represented by coarsely sampled VF tests due to
spatial aliasing.1 Because GOANNA will more densely sample in
some regions than others, the ability to truthfully represent the
spatial pattern of the underlying VF loss will vary across the
field. In this study we present simulation results that are based
on empirical data from size III white-on-white targets, however,
GOANNA is a thresholding algorithm that could be applied to
other stimuli. The effect of sampling errors on test–retest
variability should be reduced by using larger, smooth edged
stimuli.1 In such a case, a base stimulus grid for GOANNA could
involve continuous tiling of the central 308 of VF.
Another factor that might feed into the selection of seed
locations is the idea of giving importance to regions that are
more likely to progress or would have greater implications on
quality of life. For example, more seed points could be placed
FIGURE 7. Boxplots of MD for ZEST (top) and GOANNA (middle) for
each of the 23 fields for the typical FP responder. The bottom panel
illustrates the difference in interquartile range of MD between ZEST
and GOANNA. Positive differences indicate that GOANNA displays
lower variability, whereas negative differences indicate that ZEST
displays lower variability.
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at the paracentral inferior region, which has more of a bearing
on quality of life compared with the peripheral superior
region.40–42 Assuming asymmetries within the VF, GOANNA
will always test some areas more superficially than others.
Heuristics to limit the permitted extent of this superficially
could be incorporated depending on the clinical context of the
VF assessment.
Currently, GOANNA is not disease specific. For example,
the gradient calculations are not constrained by midlines; all
active/finished locations are calculated, regardless of where
they lie with respect to the horizontal and vertical midline.
However, if required, GOANNA could be made more disease
specific by customizing the position of the seed locations. For
example, if testing for a cortical lesion, the majority of the seed
locations could be placed on either side of the vertical midline
to explore for hemianopia. Alternatively, extra heuristics could
be added to GOANNA such that gradients in areas of
importance in the VF (based on the disease of interest) are
given higher weightings.
A side effect of the GOANNA logic is that blind areas of the
field will be discovered and not tested extensively during the
field examination. Reduced testing in areas already known to
be blind has been proposed as a retest heuristic.43 The authors
suggested that locations that were blind (<0 dB) on three
consecutive tests tended to remain blind, hence omitting these
locations on future tests will not influence the ability to
determine VF progression and will save time.43 GOANNA
differs from that approach, in that GOANNA has the potential
to undersample blind areas of the VF at the initial test, because
the gradient of the VF is uniform in such areas. The ability of
GOANNA to determine VF progression falls outside the scope
of this study, however, undersampling of blind areas with a
commensurate increase in sampling in areas on scotoma
borders may confer some benefits.
In this study, although four different response error profiles
were investigated, only the typical FP responder case was
reported. In the other conditions, differences between
procedures were similar to the FP case, with minimal
FIGURE 8. Bubble plots of input threshold (A), mean absolute error (B) and mean number of presentations (C) from 50 trials on a field with a
superior arcuate defect. The right column shows input threshold (D), mean absolute error (E) and mean number of presentations (F) from 50 trials
on a normal field. Numbers highlighted in bold denote 24-2 locations. The sizes of the circles are proportional to the number within those circles.
Thresholds of 1 dB indicate that the stimulus was not seen when 0 dB was presented.
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differences in absolute error when locations were pooled, and
GOANNA displaying lower absolute error when Max_d is high.
In practice it is highly unlikely that a given patient would
respond as an ‘‘unreliable responder’’ (20% FP, 20% FN), as
they would have to give both FP and FN responses in equal
proportions. This situation is best avoided by adequate patient
training and instruction. False negative responses are difficult
to interpret as it is hard to discern whether it is a true false
response or due to pathology. Higher rates of FN responses
have been reported among glaucoma patients compared with
healthy subjects.44–48 The more likely chance that an observer
would give a FN response would be in regions within a
scotoma due to a flatter frequency of seeing slope, in which
case it would not be deemed a FN response but their true
response.44–48
To conclude, we have introduced a novel algorithmic
approach to selecting test locations on a fine grid autono-
mously during the test. GOANNA was shown to improve the
characterization of scotomata in regions surrounding scotoma-
ta edges. Although a 38 grid was investigated, the general
principles of GOANNA hold for any grid resolution or test
pattern. Further testing is required to see if this improvement
in the characterization of scotoma borders leads to earlier
detection of VF progression.
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